Omega Fund Management’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
Other funds holding KYNB
SCM
Omega Fund Management's KYNB Position: Q4 2021 in Review
Omega Fund Management sold out of Kyntra Bio (KYNB) in Q4 2021, closing a stake of 5,226 shares — an estimated $1.15M sold.
Omega Fund Management first reported a position in KYNB in Q4 2014 and held it in 28 quarters. The position peaked at $30.5M in Q1 2015. 162 funds tracked by Wall St. Rank hold KYNB as of Q4 2021.
- Omega Fund Management reported no remaining Kyntra Bio position as of Q4 2021 after selling out during the quarter.
- Omega Fund Management sold 5,226 Kyntra Bio shares in Q4 2021, an estimated $1.15M.
- Omega Fund Management first reported a position in Kyntra Bio in Q4 2014 and held it in 28 quarters.
- Omega Fund Management's Kyntra Bio position peaked at $30.5M in Q1 2015.
- 162 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2021.
Based on Omega Fund Management's 13F filing for Q4 2021, filed 14 Feb 2022.